Afzal A (2020) Molecular diagnostic technologies for COVID-19: Limitations and challenges. Journal of Advanced Research 10.1016/j.jare.2020.08.002. doi:10.1016/j.jare.2020.08.002.

Almazán F, DeDiego ML, Sola I, Zuñiga S, Nieto-Torres JL, Marquez-Jurado S, Andrés G, Enjuanes L (2013) Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate. MBio 4: 1-11.

Al-Amri SS, Abbas AT, Siddiq LA, Alghamdi A, Sanki MA, Al-Muhanna MK, Alhabbab RY, Azhar EI, Li X, Hashem AM (2017) Immunogenicity of candidate MERS-CoV DNA vaccines based on the spike protein. Scientific Reports 7: 44875.

Arumugam VA, Thangavelu S, Fathah Z, et al. (2020) COVID-19 and the World with Co-Morbidities of Heart Disease, Hypertension and Diabetes. Journal of Pure and Applied Microbiology 14(3):1623-1638. doi: 10.22207/JPAM.14.3.01

Azhar EI, Hui DS, Memish ZA, Drosten C, Zumla A (2019) The middle east respiratory syndrome (MERS). Infectious Disease Clinics of North America 33: 891-905.

Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL (2004) Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. The Lancet 363: 2122-2127.

Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R (2020) Features, evaluation and treatment coronavirus (COVID-19). StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554776/, accessed on 13 July 2020.

Centers for Disease Control and Prevention (2020a) Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons for Coronavirus Disease 2019 (COVID-19). Available at https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html, accessed on 13 July 2020.

Centers for Disease Control and Prevention (2020b) People who are at higher risk for severe illness. Available at https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html, accessed on 13 July 2020.

Centers for Disease Control and Prevention (CDC) (2003) Prevalence of IgG antibody to SARS-associated coronavirus in animal traders--Guangdong Province, China, 2003. Morbidity and Mortality Weekly Report 52: 986-987.

Chafekar A, Fielding BC (2018) MERS-CoV: understanding the latest human coronavirus threat. Viruses 10: 93.

Chan KH, Poon LL, Cheng VC, Guan Y, Hung IF, Kong J, Yam LY, Seto WH, Yuen KY, Peiris JS (2004) Detection of SARS coronavirus in patients with suspected SARS.  Emerging infectious Diseases 10: 294-299.

Chen L, Zhao J, Peng J, Li X, Deng X, Geng Z, Shen Z, Guo F, Zhang Q, Jin Y, Wang L, Wang S (2020a) Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell proliferation 19:e12923. doi: 10.1111/cpr.12923.

Chen WH, Strych U, Hotez PJ, Bottazzi ME (2020b) The SARS-CoV-2 Vaccine Pipeline: an Overview. Current Tropical Medicine Reports Mar 3:1-4.

Cheng MP, Papenburg J, Desjardins M, Kanjilal S, Quach C, Libman M, Dittrich S, Yansouni CP (2020) Diagnostic Testing for Severe Acute Respiratory Syndrome-Related Coronavirus-2: A Narrative Review. Annals of Internal Medicine M20-1301.

Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S (2020) The COVID-19 pandemic. Critical Reviews in Clinical Labortatory Sciences 57(6):365-388.

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020) The species severe acute respiratory syndrome related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology 5: 536–544.

Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nature Reviews Microbiology 17: 181-192.

Czub M, Weingartl H, Czub S, He R, Cao J (2005) Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets. Vaccine 23: 2273-2279.Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020a) Coronavirus Disease 2019-COVID-19. Clinical Microbiology Reviews 33(4):e00028-20.

Dhama K, Patel SK, Sharun K, Pathak M, Tiwari R, Yatoo MI, Malik YS, Sah R, Rabaan AA, Panwar PK, Singh KP, Michalak I, Chaicumpa W, Martinez-Pulgarin DF, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020b) SARS-CoV-2 jumping the species barrier: zoonotic lessons from SARS, MERS and recent advances to combat this pandemic virus. Travel Medicine and Infectious Disease 101830. doi: 10.1016/j.tmaid.2020.101830.

Dhama K, Patel SK, Kumar R, Rana J, Yatoo MI, Kumar A, Tiwari R, Dhama J, Natesan S, Singh R, Harapan H. (2020c) Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond. Frontier Public Health. 8:574198. doi: 10.3389/fpubh.2020.574198. 

Dhama K, Patel SK, Pathak M, Yatoo MI, Tiwari R, Malik YS, Singh R, Sah R, Rabaan AA, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020a) An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies. Travel Medicine and Infectious Disease 101755.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S (2009) The spike protein of SARS-CoV—a target for vaccine and therapeutic development. Nature Review Microbiology 7: 226-236.

Du L, Yang Y, Zhou Y, Lu L, Li F, Jiang S (2017) MERS-CoV spike protein: a key target for antivirals. Expert Opinion on Therapeutic Targets 21: 131-143.

Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, Berger A. (2003) Identification of a novel coronavirus in patients with severe acute respiratory syndrome. New England Journal of Medicine 348: 1967-1976.

Fathizadeh H, Taghizadeh S, Safari R, Khiabani SS, Babak B, Hamzavi F, Ganbarov K, Esposito S, Zeinalzadeh E, Dao S, Köse ?, Kafil HS (2020) Study presence of COVID-19 (SARS-CoV-2) in the sweat of patients infected with Covid-19. Microbial pathogenesis 149:104556. doi: 10.1016/j.micpath.2020.104556.

Fehr AR, Perlman S (2015) Coronaviruses: an overview of their replication and pathogenesis. Methods in Molecular Biology 1282:1-23. doi: 10.1007/978-1-4939-2438-7_1.

Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, Butt KM (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302: 276-278.

Han D, Li R, Han Y, Zhang R, Li J (2020) COVID-19: Insight into the asymptomatic SARS-COV-2 infection and transmission. International journal of biological sciences 16(15):2803-2811. doi: 10.7150/ijbs.48991.

Bharat Biotech (2020) Available at https://www.bharatbiotech.com/covaxin.html. Accessed on October 10, 2020.

Hui DS, Azhar EI, Kim YJ, Memish ZA, Oh MD, Zumla A. (2018) Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. The Lancet Infectious Diseases 18: e217-e227.

Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D (2020) Inflammation Triggered by SARS-CoV-2 and ACE2 Augment Drives Multiple Organ Failure of Severe COVID-19: Molecular Mechanisms and Implications. Inflammation 1–22. doi: 10.1007/s10753-020-01337-3.

Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ. (2020) An mRNA vaccine against SARS-CoV-2—preliminary report. The New England Journal of Medicine NEJMoa2022483.

Karthik K, Aravindh Babu RP, Dhama K, Chitra MA, Kalaiselvi G, Alagesan Senthilkumar TM, Raj GD (2020) Biosafety Concerns During the Collection, Transportation, and Processing of COVID-19 Samples for Diagnosis. Archives of Medical Research S0188-4409(20)30889-4. doi: 10.1016/j.arcmed.2020.08.007.

Khandola A (2020) Coronavirus (COVID-19) origin: Cause and how it spreads. Available at https://www.medicalnewstoday.com/articles/coronavirus-causes, accessed on 16 October 2020.

Kim JH, Kang M, Park E, Chung DR, Kim J, Hwang ES (2019) A Simple and Multiplex Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of SARS-CoV. Biochip Journal 13(4):341-351. doi: 10.1007/s13206-019-3404-3.

Klempner MS, Shapiro DS (2004) Crossing the species barrier—one small step to man, one giant leap to mankind. New England Journal of Medicine 350: 1171-1172.

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, Rollin PE (2003) A novel coronavirus associated with severe acute respiratory syndrome. New England journal of medicine 348: 1953-1966.

Lai T, Xiang F, Zeng J, Huang Y, Jia L, Chen H, Wu J, Xie J, Liu S, Deng W, Zheng W, Huang Y, Zhang Q, Luo Q, Mo F, Long L, Zhang W, Chen W, Han H (2020) Reliability of induced sputum test is greater than that of throat swab test for detecting SARS-CoV-2 in patients with COVID-19: A multi-center cross-sectional study. Virulence 11(1):1394-1401. doi: 10.1080/21505594.2020.1831342.

Lei H, Li Y, Xiao S, Lin CH, Norris SL, Wei D, Hu Z, Ji S. (2018) Routes of transmission of influenza A H1N1, SARS CoV, and norovirus in air cabin: Comparative analyses. Indoor Air 28(3):394-403. doi: 10.1111/ina.12445.

Leung WK, To KF, Chan PK, Chan HL, Wu AK, Lee N, Yuen KY, Sung JJ (2003) Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125: 1011-1017.

Liu DX, Fung TS, Chong KK, Shukla A, Hilgenfeld R (2014) Accessory proteins of SARS-CoV and other coronaviruses. Antiviral Research 109: 97-109.

Luo F, Liao FL, Wang H, Tang HB, Yang ZQ, Hou W (2018) Evaluation of Antibody-Dependent Enhancement of SARS-CoV Infection in Rhesus Macaques Immunized with an Inactivated SARS-CoV Vaccine. Virologica Sinica 33(2):201-204. doi: 10.1007/s12250-018-0009-2.

Mackay IM, Arden KE (2015) MERS coronavirus: diagnostics, epidemiology and transmission. Virology Journal 12: 1-21.

Malik YS, Kumar N, Sircar S, Kaushik R, Bhat S, Dhama K, Gupta P, Goyal K, Singh MP, Ghoshal U, El Zowalaty ME, O R V, Yatoo MI, Tiwari R, Pathak M, Patel SK, Sah R, Rodriguez-Morales AJ, Ganesh B, Kumar P, Singh RK (2020) Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective. Pathogens 9(7):E519.

Menachery VD, Gralinski LE, Mitchell HD, Dinnon KH, Leist SR, Yount BL, Graham RL, McAnarney ET, Stratton KG, Cockrell AS, Debbink K (2017) Middle East respiratory syndrome coronavirus nonstructural protein 16 is necessary for interferon resistance and viral pathogenesis. MSphere 2: 1-12.

Mo HY, Xu J, Ren XL, Zeng GQ, Tan YX, Chen RC, Chan-Yeung M, Zhong NS (2005) Evaluation by indirect immunofluorescent assay and enzyme linked immunosorbent assay of the dynamic changes of serum antibody responses against severe acute respiratory syndrome coronavirus. Chinese Medical Journal (English) 118: 446-450.

Morawska L, Cao J (2020) Airborne transmission of SARS-CoV-2: The world should face the reality. Environment International 139:105730.

Mullard A (2020) COVID-19 vaccine development pipeline gears up. Lancet. 395(10239):1751-1752. doi: 10.1016/S0140-6736(20)31252-6.

Nassar MS, Bakhrebah MA, MeoSA, Alsuabeyl MS, Zaher WA (2018) Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics. European Review for Medical and Pharmacological Sciences 22: 4956-4961.

Papadakis MA, McPhee SJ, Rabow MW (2016) Medical Diagnosis & Treatment. New York: McGraw-Hill Education. McGraw-Hill, New York.

Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, Cheng VC (2003) Coronavirus as a possible cause of severe acute respiratory syndrome. The Lancet 361: 1319-1325.

Philips CA, Mohan N, Ahamed R, Kumbar S, Rajesh S, George T, Mohanan M, Augustine P (2020) One disease, many faces-typical and atypical presentations of SARS-CoV-2 infection-related COVID-19 disease. World journal of clinical cases 8(18):3956-3970. doi: 10.12998/wjcc.v8.i18.3956.

Rabaan AA, Al-Ahmed SH, Haque S, Sah R, Tiwari R, Malik YS, Dhama K, Yatoo MI, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020) SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview. Infez Med 28(2):174-184. PMID: 32275259.

Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD (2020) SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far. Pathogens 9: 231.

Rodriguez-Morales AJ, Bonilla-Aldana DK, Tiwari R, Sah R, Rabaan AA, Dhama K (2020) COVID-19, an emerging coronavirus infection: current scenario and recent developments – an overview.  Journal of Pure and Applied Microbiology 14(1): 05-12. https://doi.org/10.22207/JPAM.14.1.02

Setti L, Passarini F, De Gennaro G, Barbieri P, Perrone MG, Borelli M, Palmisani J, Di Gilio A, Piscitelli P, Miani A (2020) Airborne Transmission Route of COVID-19: Why 2 Meters/6 Feet of Inter-Personal Distance Could Not Be Enough. International Journal of Environmental Research and Public Health 17(8):E2932.

Sharma R, Akhoury G (2020) 2019-nCoV: a worldwide concern and facts. Virus disease 16:1-8. doi: 10.1007/s13337-020-00633-8.

Sharun K, Tiwari R, Dhama J, Dhama K (2020) Dexamethasone to combat cytokine storm in COVID-19: Clinical trials and preliminary evidence. International Journal of Surgery 82:179-181. doi: 10.1016/j.ijsu.2020.08.038.

Shim BS, Stadler K, Nguyen HH, Yun CH, Kim DW, Chang J, Czerkinsky C, Song MK (2012) Sublingual immunization with recombinant adenovirus encoding SARS-CoV spike protein induces systemic and mucosal immunity without redirection of the virus to the brain. Virology journal 21;9:215. doi: 10.1186/1743-422X-9-215.

Sputnik V (2020) The first registered vaccine against COVID-19. https://sputnikvaccine.com/. 2020. Accessed 30^th September 2020.

Tiwari R, Dhama K, Sharun K, Iqbal Yatoo M, Malik YS, Singh R, Michalak I, Sah R, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020) COVID-19: animals, veterinary and zoonotic links. Veterinary Quarterly 40(1):169-182. doi: 10.1080/01652176.2020.1766725.

TOI Coronavirus vaccine (2020) From Covaxin to Russian vaccine roll out, here are all the updates regarding COVID-19 vaccine development. 2020. https://timesofindia.indiatimes.com/life-style/health-fitness/health-news/coronavirus-vaccine-from-covaxin-to-russian-vaccine-roll-out-here-are-all-the-updates-regarding-covid-19-vaccine-development/photostory/78362614.cms?picid=78362622. Accessed 30^th September 2020.

Udugama B, Kadhiresan P, Kozlowski HN, Malekjahani A, Osborne M, Li VYC, Chen H, Mubareka S, Gubbay JB, Chan WCW (2020) Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano 14(4):3822-3835.

Wang MD, Jolly AM (2004) Changing virulence of the SARS virus: the epidemiological evidence. Bulletin of the World Health Organization 82: 547-548.

Weingartl H, Czub M, Czub S, Neufeld J, Marszal P, Gren J, Smith G, Jones S, Proulx R, Deschambault Y, Grudeski E (2004) Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets. Journal of virology 78: 12672-12676.

Wernery U, Lau SK, Woo PC (2017) Middle East respiratory syndrome (MERS) coronavirus and dromedaries. The Veterinary Journal 220: 75-79.

World Health Organization (2020a) Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_3, accessed on 13 July 2020.

World Health Organization (2020b). DRAFT landscape of COVID-19 candidate vaccines – 28 September 2020. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines. 2020; Accessed 30^th September 2020.

World Health Organisation (2020c) Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov), accessed on 16 October 2020.

Xu X, Gao X (2004) Immunological responses against SARS-coronavirus infection in humans. Cellular & Molecular Immunology 1: 119-122.

Xu RH, He JF, Evans MR, Peng GW, Field HE, Yu DW, Lee CK, Luo HM, Lin WS, Lin P, Li LH (2004) Epidemiologic clues to SARS origin in China. Emerging Infectious Diseases 10: 1030-1037.

Zhang CY, Wei JF, He SH (2006) Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. BMC Microbiology 6: 88.

Zhang R, Li Y, Zhang AL, Wang Y, Molina MJ (2020) Identifying airborne transmission as the dominant route for the spread of COVID-19. Procedings of the National Academy of Sciences USA 117(26):14857-14863.

Zhong NS, Zeng GQ (2003) Our strategies for fighting severe acute respiratory syndrome (SARS). American Journal of Respiratory and Critical Care Medicine 168: 7-9.

Zhong NS, Zheng BJ, Li YM, Poon LL, Xie ZH, Chan KH, Li PH, Tan SY, Chang Q, Xie JP, Liu XQ (2003) Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February. The Lancet 362: 1353-1358.

Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, Yang Y (2005) B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. Journal of Virology 79: 3401-3408.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet 395: 1054-1062.

Zhou T, Wang H, Luo D, Rowe T, Wang Z, Hogan RJ, Qiu S, Bunzel RJ, Huang G, Mishra V, Voss TG (2004) An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies. Journal of Virology 78: 7217-7226.

Yatoo MI, Hamid Z, Parray OR, Wani AH, Ul Haq A, Saxena A, Patel SK, Pathak M, Tiwari R, Malik YS, Sah R, Rabaan AA, Rodriguez Morales AJ, Dhama K (2020) COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines. Human Vaccines and Immunotherapeutics 1-14. doi: 10.1080/21645515.2020.1788310.